| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/17/2004 | US6694171 Nontoxic conjugate or complex of contrast agent having element with abrupt change in x-ray attenuation coefficient within specified energy range and macromolecular carrier containing high loading of element through high affinity binding groups |
| 02/17/2004 | US6693190 Tetraazacyclododecane macrocycle derivatives including metal complexes; magnetic resonance imaging agents |
| 02/17/2004 | CA2145505C Microparticle preparations made from biodegradable copolymers |
| 02/12/2004 | WO2004013180A2 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
| 02/12/2004 | WO2004013161A2 Peptide aggregates |
| 02/12/2004 | WO2003101279A3 Magnetic resonance imaging of metal concentrations |
| 02/12/2004 | WO2003088823A3 Novel macrocyclic activatible magnetic resonance imaging contrast agents |
| 02/12/2004 | WO2003033670A3 Method for preparation of single chain antibodies |
| 02/12/2004 | WO2002074346A3 Targeting chemical compounds to cells |
| 02/12/2004 | US20040030252 Methods for ultrasonic imaging and treating diseased tissues |
| 02/12/2004 | US20040029996 Bone cement mixture and x-ray contrast medium as well as method for their preparation |
| 02/12/2004 | US20040029963 Use of pamoic acid or one of its derivatives, or one of its analogues , for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 02/12/2004 | US20040028611 Diagnosis of anticholesterol agents; cardiovascular disorders; in situ detection of apatite |
| 02/12/2004 | US20040028610 Administering androgen |
| 02/12/2004 | US20040028609 Two-dimensionally quantified image method for distinguishing and quantifying over-growing tissue or the like |
| 02/12/2004 | DE10231799A1 Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben Use of perfluoroalkyl-containing metal complexes as contrast agents in MR imaging for the representation of intravascular thrombi |
| 02/12/2004 | DE10154016B4 Magnetflüssigkeit und Verfahren zur ihrer Herstellung Magnetic fluid and process for its preparation |
| 02/12/2004 | CA2494310A1 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
| 02/11/2004 | EP1387886A2 Proteases |
| 02/11/2004 | EP1387825A1 Thyroid hormone receptor antagonists for cardiac & metabolic disorders ii |
| 02/11/2004 | EP1387700A2 Methods and devices for moisturizing hyperpolarized noble gases and pharmaceutical products thereof |
| 02/11/2004 | EP1387637A2 Method for improved measurement of local physical parameters in afluid-filled cavity |
| 02/11/2004 | EP1290035B1 Fluorescein isothiocyanate (fitc) sinistrin, its production and use |
| 02/11/2004 | EP1176987B1 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics |
| 02/11/2004 | EP0755385B1 Chelant compounds |
| 02/11/2004 | CN1473558A Compound function supermicro magnetic carrier particle and its preparing method |
| 02/11/2004 | CN1138154C Method of magnetic resonance investigation |
| 02/11/2004 | CN1137732C Detection of H. pylori in stomach |
| 02/11/2004 | CN1137731C Non-invasive localization of light-emitting conjugate in mammal animal |
| 02/11/2004 | CN1137726C Method of prolonged suppression of humoral immunity |
| 02/10/2004 | US6690962 Process for graphic visualization and diagnosis of thrombi by means of nuclear spin tomography with use of particulate contrast media |
| 02/10/2004 | US6689936 Administering compound to live transgenic mouse whose genome comprises dna sequence encoding luminescent or fluorescent reporter polypeptide coupled to vascular endothelial growth factor or versican promoter, evaluating expression in skin |
| 02/10/2004 | US6689876 Cloning and sequencing of allergens of dermatophagoides |
| 02/10/2004 | US6689616 Dye-polysaccharide conjugates and their use as a diagnostic agent |
| 02/10/2004 | US6689337 Vitronectin receptor antagonist pharmaceuticals |
| 02/10/2004 | US6688311 Method for determining effect of a clostridial toxin upon a muscle |
| 02/05/2004 | WO2004011936A1 Synthesis and purification of highly conjugated polymers |
| 02/05/2004 | WO2004011426A2 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| 02/05/2004 | WO2004011036A1 Method for assessing capillary permeability |
| 02/05/2004 | WO2004011035A2 Bio-degradable microspheres for diagnosing gastroesophagal reflux |
| 02/05/2004 | WO2004011034A1 Conjugated lysine copolymers for drug delivery and imaging |
| 02/05/2004 | WO2004010953A2 Implantable artificial organ devices |
| 02/05/2004 | WO2004010934A2 Methods for the use of neurotoxin in the treatment of urologic disorders |
| 02/05/2004 | WO2004010868A2 Method for binding molecular agents to angiogencic blood vessels |
| 02/05/2004 | WO2004010841A2 Method for assessing myocardial angiogenesis |
| 02/05/2004 | WO2003076651A3 Cancer associated araf1 protein kinase and its uses |
| 02/05/2004 | WO2002094378A3 Increased functional activity and/or expression of abc transporters protects against the loss of dopamine neurons associated with parkinson's disease |
| 02/05/2004 | US20040024318 Intravenously administering a polymeric contrast agent to a patient for monitoring myocardial antiogenesis, the polymeric contrast agent having a polypeptide backbone attached with it a steric hindrance molecule, and a gadolinium ion is chelated |
| 02/05/2004 | US20040024317 Intravenously administering a polymeric contrast agent to a patient, obtaining at least two images of tissue of the patient and comparing the images to assess the permeability of a blood vessel |
| 02/05/2004 | US20040024307 Para-hydrogen labeled agents and their use in magnetic resonance imaging |
| 02/05/2004 | US20040024220 Lipids |
| 02/05/2004 | US20040023912 Method of diagnosis and treatment of breast lesions |
| 02/05/2004 | US20040023415 Biospecific contrast agents |
| 02/05/2004 | US20040022865 Micro-clustered liquids; inhibiting the frequency of mutation of genetic material |
| 02/05/2004 | US20040022857 Activating a steric hindrance molecule that can complex lanthanide ions, especially reacting DTPA with triethylamine, to form the anhydride; and reacting the activated molecule with a polymer, especially a polypeptide; MRI diagnosis |
| 02/05/2004 | US20040022737 Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 02/05/2004 | US20040022736 Administering polypeptide to mammal to detectably bind to parenchymal deposits, detecting polypeptide bound to deposits, detecting step comprising acquiring nuclear magnetic resonance image data and reconstructing an image therefrom |
| 02/05/2004 | US20040022735 Enzyme activated contrast agents |
| 02/05/2004 | US20040022734 For therapy of cancer, of fluorescent imaging and optoelectronics |
| 02/05/2004 | US20040022733 Conjugated lysine copolymers |
| 02/05/2004 | US20040022732 For nuclear magnetic resonance, for diagnosis or therapy, such as magnetic resonance imaging |
| 02/05/2004 | US20040022731 In vivo imaging of apoptosis |
| 02/05/2004 | US20040022730 Fluorescent isothiocyanate (fitc) sinistrin, its production and use |
| 02/05/2004 | US20040022729 Sequential injections of contrast agents are employed for assessing angiogenic activity; at least one of the injections is of a polymeric contrast agent which binds to angiogenic microvasculature |
| 02/05/2004 | US20040022728 Measuring metabolic clearance for the 6 beta - hydroxylation of cortisol in subject as an index cytochrome P450 3A (CYP3A) activity without use of labeled exogenous cortisol |
| 02/05/2004 | US20040022725 Stable radioiodine conjugates and methods of their synthesis |
| 02/05/2004 | US20040021771 Method and apparatus for 3-D imaging of internal light sources |
| 02/05/2004 | CA2494715A1 Method for automated, large-scale measurement of the molecular flux rates using mass spectrometry |
| 02/04/2004 | EP1386934A1 Diagnostic agents for pancreatic exocrine function |
| 02/04/2004 | EP1386927A1 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors |
| 02/04/2004 | EP1386618A2 High volume hyperpolarizer for spin-polarized noble gas |
| 02/04/2004 | EP1385955A2 Cell adhesion proteins |
| 02/04/2004 | EP1385480A1 Liposomes |
| 02/04/2004 | EP1385476A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 02/04/2004 | EP1107799B1 Method for labeling biopolymers using isotopes |
| 02/04/2004 | EP0576521B2 Improvements in or relating to contrast agents |
| 02/04/2004 | CN1472235A Folic acid-polydiol compound and its medicinal composition |
| 02/04/2004 | CN1137087C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/03/2004 | US6686334 Decrease hyperalgesia, without impairing nociception |
| 02/03/2004 | US6685915 Extended-linear polymeric contrast agents, and synthesizing methods, for medical imaging |
| 01/31/2004 | CA2432676A1 Development of an in vivo functional assay for proteases |
| 01/29/2004 | WO2004010045A1 Automated dynamic pressure-responsive hyperpolarized gas dispensing systems, and associated methods and computer program products |
| 01/29/2004 | WO2004009134A1 Procedures of cellular labelling with paramagnetic complexes for mri applications |
| 01/29/2004 | WO2004009082A1 Oxime conjugates and methods for their formation and use |
| 01/29/2004 | WO2003101948A3 Agents for imaging and diagnostic methods using them |
| 01/29/2004 | WO2003015617A3 Assay method for alzheimer's disease |
| 01/29/2004 | WO2002083381B1 Method and compositions for inhibiting cellulolytic symbionts |
| 01/29/2004 | WO2002072794A3 Immunoglobulin superfamily proteins |
| 01/29/2004 | US20040019095 N, N'-dimethylated N-confused porphyrins |
| 01/29/2004 | US20040018151 Method of screening for compounds useful for promoting normal motor function in ALS patients is provided. The screening method comprises (a) administering a compound that is a anandamide/cannabinoid |
| 01/29/2004 | US20040018148 Conjugating radioiodinated peptides or carbohydrate structures to proteins with improved yields and qualities of conjugates. In one method, specially designed radioiodinated bifunctional peptides containing nonmetabolizable amide bonds are coupled |
| 01/29/2004 | US20040016768 Automated dynamic pressure-responsive dispensing systems, and associated methods and computer program products |
| 01/28/2004 | EP1384488A2 Method and kit for imaging organs and tissues, using labelled antibodies |
| 01/28/2004 | EP1383918A2 An animal model for enteric pathogens |
| 01/28/2004 | EP1383892A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/28/2004 | EP1383740A2 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors |
| 01/28/2004 | EP1383543A1 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 01/28/2004 | EP1383542A1 In vivo method for measuring binding of chemical actives to skin or specific constituents of skin |
| 01/28/2004 | EP0914345B1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 01/28/2004 | CN1471523A Imidazole derivatives as Raf kinase inhibitors |